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Abstract
Background: Saturated fatty acids are toxic to liver cells and are believed to play a central role in the pathogenesis of
non-alcoholic steatohepatitis. In experimental steatohepatitis induced by feeding mice a methionine-choline-deficient
(MCD) diet, the degree of liver damage is related to dietary sugar content, which drives de novo lipogenesis and
promotes the hepatic accumulation of saturated fatty acids. The objective of this study was to determine whether
dietary palmitate exerts the same toxicity as carbohydrate-derived palmitate in the MCD model of fatty liver disease.
Methods: We fed mice custom MCS and MCD formulas containing 4 different carbohydrate-fat combinations: starch-oleate,
starch-palmitate, sucrose-oleate and sucrose-palmitate. After 3 wk, we compared their metabolic and disease outcomes.
Results: Mice fed the custom MCD formulas developed varying degrees of hepatic steatosis and steatohepatitis, in
the order starch-oleate < starch-palmitate < sucrose-oleate < sucrose-palmitate. Liver injury correlated positively with
the degree of hepatic lipid accumulation. Liver injury also correlated positively with the amount of palmitate in the liver, but
the relationship was weak. Importantly, mice fed MCD starch-palmitate accumulated as much hepatic palmitate as
mice fed MCD sucrose-oleate, yet their degree of liver injury was much lower. By contrast, mice fed MCD sucrose-
palmitate developed severe liver injury, worse than that predicted by an additive influence of the two nutrients.
Conclusion: In the MCD model of steatohepatitis, carbohydrate-derived palmitate in the liver is more hepatotoxic than
dietary palmitate. Dietary palmitate becomes toxic when combined with dietary sugar in the MCD model, presumably
by enhancing hepatic de novo lipogenesis.
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Background
Saturated fatty acids (SFA) are important mediators of
hepatic lipotoxicity [1–5] and have been implicated in
the pathogenesis of non-alcoholic steatohepatitis (NASH).
This is particularly true in the case of experimental NASH
induced by a methionine-choline-deficient (MCD) diet
[3, 6]. MCD feeding induces at least two major alterations
in hepatic lipid metabolism that contribute to SFA
accumulation in the liver: it impairs hepatic lipid export by
interfering with VLDL synthesis [6, 7], and suppresses
stearoyl-CoA desaturase-1 (SCD1) through an as-yet
unidentified mechanism [8]. SFA accumulation in the livers
of MCD-fed mice and the accompanying liver injury can be
modulated by altering the carbohydrate composition of the
MCD formula. Our laboratory has shown that enriching
the diet with simple sugar enhances steatohepatitis,
whereas substituting dietary sugar with complex carbohy-
drate reduces liver injury [6, 9]. These studies indicate that
sucrose-stimulated de novo lipogenesis (DNL) is an im-
portant prerequisite to liver pathology in the MCD model.
Specifically, they implicate palmitate (C16:0), the product
of DNL, as a mediator of steatohepatitis in vivo.
It is known that hepatic fatty acids derive from three
sources: dietary fat, hepatic DNL and adipose tissue lip-
olysis. Having demonstrated that DNL-derived palmitate
is injurious to the liver of MCD-fed mice, we questioned
whether palmitate within dietary fat is similarly hepatotoxic.
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Evidence indicates that different types of fatty acids
(saturated, unsaturated, polyunsaturated) undergo different
metabolic fates in animals and humans [10–14], but it is
unknown whether the same fatty acid always behaves
identically regardless of its origin (diet or DNL). The object-
ive of this study was to compare the hepatotoxicity of
MCD formulas in which hepatic palmitate derives primar-
ily from DNL, primarily from the diet, or both.



















L-arginine (free base) 6.3 6.3 6.3 6.3 6.3 6.3 6.3 6.3
L-histidine (free base) 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5
L-lysine 16.1 16.1 16.1 16.1 16.1 16.1 16.1 16.1
L-tyrosine 9.2 9.2 9.2 9.2 9.2 9.2 9.2 9.2
L-tryptophan 2.1 2.1 2.1 2.1 2.1 2.1 2.1 2.1
L-phenylalanine 8.7 8.7 8.7 8.7 8.7 8.7 8.7 8.7
L-cysteine 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.7
L-threonine 6.6 6.6 6.6 6.6 6.6 6.6 6.6 6.6
L-leucine 15.3 15.3 15.3 15.3 15.3 15.3 15.3 15.3
L-isoleucine 8.4 8.4 8.4 8.4 8.4 8.4 8.4 8.4
L-valine 9.9 9.9 9.9 9.9 9.9 9.9 9.9 9.9
Glycine 3.1 3.1 3.1 3.1 3.1 3.1 3.1 3.1
L-proline 20.4 20.4 20.4 20.4 20.4 20.4 20.4 20.4
L-glutamic acid 36.2 36.2 36.2 36.2 36.2 36.2 36.2 36.2
L-alanine 4.5 4.5 4.5 4.5 4.5 4.5 4.5 4.5
L-aspartic acid 11.3 11.3 11.3 11.3 11.3 11.3 11.3 11.3
L-serine 9.4 9.4 9.4 9.4 9.4 9.4 9.4 9.4
Carbohydrate (g/kg)
Cornstarch 587.9 587.9 0.0 0.0 591.9 591.9 0.0 0.0
Dyetrose 50.0 50.0 50.0 50.0 50.0 50.0 50.0 50.0
Sucrose 0.0 0.0 587.9 587.9 0.0 0.0 591.9 591.9
Cellulose 30.0 30.0 30.0 30.0 30.0 30.0 30.0 30.0
Fat (g/kg)
Tripalmitin 0.0 100.0 0.0 100.0 0.0 100.0 0.0 100.0
High-oleate (85 %)
sunflower oil
100.0 0.0 100.0 0.0 100.0 0.0 100.0 0.0
Methionine and choline (g/kg)
L-methionine 2.0 2.0 2.0 2.0 0.0 0.0 0.0 0.0
Choline chloride 2.0 2.0 2.0 2.0 0.0 0.0 0.0 0.0
Additives (g/kg)
Salt mix #210030 35.0 35.0 35.0 35.0 35.0 35.0 35.0 35.0
Sodium bicarbonate 7.4 7.4 7.4 7.4 7.4 7.4 7.4 7.4
Vitamin Mix #310025 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0
Total (g/kg) 1000.0 1000.0 1000.0 1000.0 1000.0 1000.0 1000.0 1000.0
Protein 18 % 18 % 18 % 18 % 18 % 18 % 18 % 18 %
CHO 64 % 64 % 64 % 64 % 64 % 64 % 64 % 64 %
Fat 10 % 10 % 10 % 10 % 10 % 10 % 10 % 10 %
Fiber 3 % 3 % 3 % 3 % 3 % 3 % 3 % 3 %
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Methods
Dietary studies
Adult male C3H/HeOuJ mice (The Jackson Laboratory,
Bar Harbor, ME) were fed for 21 days ad libitum with one
of 8 custom methionine-choline-sufficient (MCS) or MCD
formulas (Dyets, Inc., Bethlehem, PA). Each formula
contained a unique combination of carbohydrate and fat as
detailed in Table 1. The formulas were named for their
primary carbohydrates and fats: starch-oleate, starch-
palmitate, sucrose-oleate and sucrose-palmitate. All formu-
las contained 18 % protein, 64 % carbohydrate and 10 % fat
by weight. Paired MCS and MCD formulas were matched
for all nutrients except L-methionine and choline chloride.
At the end of the study period, mice were fasted for 4 h
prior to killing. Serum alanine aminotransferase (ALT)
was measured on an ADVIA 1800 autoanalyzer (Siemens
Healthcare Diagnostics, Deerfield, IL).
All animals received humane care according to guide-
lines published by the US Public Health Service. All
experimental procedures were approved by the Institu-
tional Animal Care and Use Committee at the University
of California, San Francisco.
Triglyceride and fatty acid analysis
Lipids were extracted from fresh liver tissue using the
Folch method [15]. Aliquots were dried and resus-
pended in 1-butanol containing 0.01 % butyrated
hydroxytoluene for measurement of total triglyceride
(TR0100; Sigma Chemical Co., St. Louis, MO). Fatty
acid analysis was performed on flash-frozen liver tissue.
Lipid extraction and TrueMass® neutral lipid analysis were
performed by Lipomics Technologies (West Sacramento,
CA). Tissue samples were subjected to a combination of
liquid- and solid-phase extraction procedures to separate
neutral lipids from phospholipids, followed by thin-layer
chromatography to separate neutral lipid classes and gas
chromatography to quantitate individual fatty acids. All
samples were processed in the presence of internal stan-
dards to monitor extraction efficiency and verify measure-
ment accuracy.
Evaluation of gene expression
Total RNA was extracted from liver using TRIzol re-
agent (Life Technologies, Carlsbad, CA) and purified
using the RNeasy kit (Qiagen, Valencia, CA). RNA integ-
rity was verified by formaldehyde gel electrophoresis.
cDNA was synthesized using iScript (BioRad, Hercules,
CA); quantitative PCR was performed with TaqMan®
assay kits (Life Technologies, Carlsbad, CA) using β-
glucuronidase as the internal control gene.
Histologic analyses
Formalin-fixed, paraffin-embedded sections of liver tis-
sue were stained with hematoxylin and eosin for routine
Fig. 1 Weight gain/loss on MCS and MCD diets. a 21-day weight curve for mice fed MCS formulas. b 21-day weight curve for mice fed MCD formulas.
Values represent mean ± SE for n = 10. Superscripts indicate P < 0.05 vs. comparison groups by number
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histology. Apoptotic cells were identified in liver sections
by terminal deoxynucleotide transferase-mediated deox-
yuridine triphosphate nick end-labeling (TUNEL) (Apop-
Tag Plus Peroxidase In Situ Apoptosis Detection Kit,
Millipore, Billerica, MA). To assess hepatic inflammation,
liver sections were stained with anti-CD11b (Abcam,
Cambridge, MA). Collagen deposition was assessed by
Sirius Red staining. Counting of TUNEL-positive or
CD11b-positive cells was performed manually in 10 micro-
scopic fields per liver, each measuring 0.4 mm2. Data were
reported as the average number of cells per microscopic
field. Sirius red-stained area was assessed by morphometry
(Simple PCI, Hamamatsu Corporation, Sewickley, PA).
Statistical methods
Experiments included 10 mice per diet group, performed
in 2 separate cohorts of 5. Some outcome measures were
assessed in only one cohort as described in the figure
legends. Results were compared by analysis of variance
with Tukey post-hoc testing. P values < 0.05 were consid-
ered statistically significant.
Results and discussion
Mice were fed custom MCS and MCD diets that differed
from commercial MCS and MCD formulas by being
nearly completely enriched with a single type of carbohy-
drate (sucrose or starch) or fat (palmitate or oleate). The
custom MCS and MCD mixtures were designed to
maximize palmitate accumulation in the liver via DNL
(with sucrose) or diet (with palmitate) or both. Starch
served as the control to sucrose, whereas oleate served as
the control to palmitate. Mice in all 8 dietary groups ate
comparable amounts of food during the study period.
Animals fed MCS formulas gained weight (14.7 ± 1.3 %),
whereas those fed MCD formulas lost weight (28.8 ±
1.0 %), which is characteristic for the dietary model [8]. All
MCD-fed mice lost comparable amounts of weight regard-
less of the macronutrient composition of the diet (Fig. 1b).
MCD feeding is unique in that it does not induce insulin
resistance or hyperglycemia coincident with steatohepatitis
[16]. This pattern did not change with the 4 custom MCD
diets; there was no evidence of insulin resistance or hyper-
glycemia in any MCD group (not shown).
Fig. 2 Hepatic lipid accumulation in mice fed custom MCS and MCD diets. a Photomicrographs illustrate liver histology after 21 days of MCS or
MCD feeding. There was no apparent steatosis in any of the MCS-fed groups. MCD diets induced histologic steatosis of varying degrees depending
upon macronutrient composition. Bar = 100 μm. b Total hepatic triglyceride measured biochemically in MCS and MCD livers at 21 days. Values
represent mean ± SE for n = 10. c Total hepatic fatty acid content measured by gas chromatography and d total hepatic fatty acid segregated
by SFA, MUFA and PUFA. Values represent mean ± SE for n = 5. St Ol = Starch Oleate, St Palm = Starch Palmitate, Suc Ol = Sucrose Oleate, Suc
Palm = Sucrose Palmitate. Superscripts indicate P < 0.05 vs. MCD comparison groups by number
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After 3 weeks on the custom diets, MCS-fed mice
remained free of histologic hepatic steatosis. By con-
trast, MCD-fed mice developed markedly different de-
grees of hepatic steatosis depending on macronutrient
composition. This was evident histologically (Fig. 2a) and
confirmed by hepatic lipid quantitation [6, 9] (Fig. 2b and
c). MCD formulas containing sucrose induced the most
pronounced hepatic steatosis regardless of the accom-
panying type of dietary fat. The worst steatosis oc-
curred in mice fed MCD diets containing both sucrose
and palmitate.
Mice fed MCD formulas containing sucrose also ex-
hibited the greatest degrees of liver injury, as shown by
TUNEL staining and serum ALT (Fig. 3). Just as it in-
duced the most steatosis, the MCD formula containing
both sucrose and palmitate caused the worst hepatotox-
icity. Accompanying the liver injury in MCD-fed mice
was hepatic activation of Jun-N-terminal kinase (JNK);
the greatest degree of JNK activation occurred in the
sucrose-palmitate group. In addition to JNK, the necrop-
tosis marker receptor-interacting protein kinase 3 (RIP3)
was mildly upregulated in response to MCD feeding.
RIP3 was most visible in mice fed sucrose-palmitate.
LC3, a marker of autophagosomes, was up-regulated in
mice fed MCD sucrose-palmitate, but also in mice fed
MCD starch-palmitate. This suggests dietary fat is affect-
ing hepatic autophagy either positively or negatively, but
without a firm relationship to liver injury. Overall the
data support the notion that dietary sucrose activates
cytotoxicity pathways known to be operative in steatohe-
patitis (JNK, RIP3) [17, 18], and the addition of dietary
palmitate accentuates these events.
Hepatocellular injury in MCD-fed mice was accom-
panied by the induction of pro-inflammatory genes in
the liver and the hepatic influx of CD11b-positive leuko-
cytes (Fig. 4). The degree of hepatic inflammation mir-
rored the degree of hepatocellular injury in all MCD-fed
groups. Stellate cell activation, characterized by the in-
duction of type I collagen mRNA in the liver, was also
affected by diet; again, MCD sucrose-palmitate provided
the greatest stimulus to collagen gene regulation. Despite
robust collagen gene induction in the livers of MCD-
fed mice, there was no increase in smooth muscle-alpha-
actin expression (Fig. 3c). Nor was there any evidence of
Fig. 3 Liver injury in mice fed custom MCD diets. a Photomicrographs illustrate TUNEL staining in mice fed custom MCD formulas for 21 days.
TUNEL-positive cells are marked with arrowheads. Bar = 100 μm. There were no TUNEL-stained cells in mice fed MCS formulas over this interval
(not shown). b Graphs depict TUNEL- positive cells (average number of cells per 0.4 mm2 section) and serum ALT in MCD-fed livers. Values repre-
sent mean ± SE for n = 5 (TUNEL) and n = 10 (ALT). Superscripts indicate P < 0.05 vs. MCD comparison groups by number. c Western blots illustrate
JNK phosphorylation and hepatic expression of of RIP3, smooth muscle actin (SMA) and LC3 in MCS- and MCD-fed mice. Tubulin is shown as a
loading control. St O = Starch Oleate, St P Starch Palmitate, Suc O = Sucrose Oleate, Suc P = Sucrose Palmitate
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collagen deposition in the liver by morphometry (<0.5 %
Sirius Red-stained area in all groups). This suggests that
collagen gene induction reflects acute liver injury rather
than fibrosis at the 3-weeks time point, but portends fibro-
sis over a longer interval.
After characterizing the effects of the 4 custom MCD
formulas on liver injury, we explored whether the different
outcomes of the 4 diets could be attributed to differences
in hepatic palmitate accumulation. Hepatic palmitate
levels rose above control values in MCD-fed mice whose
diets contained sucrose or palmitate or both (Fig. 5a).
Although palmitate levels tended to correlate positively
with ALT levels in these MCD groups, the relationship
was not strong (Fig. 5b). Indeed, as shown in Fig. 5c, mice
fed MCD sucrose-oleate accumulated no more palmitate
than those fed MCD starch-palmitate, yet their ALT levels
were significantly higher. This suggests that palmitate aris-
ing from sucrose in the diet (DNL palmitate) is more hep-
atotoxic than palmitate coming directly from the diet in
the MCD model of liver disease. We assessed lipogenic
gene expression in all mice, although previous studies have
shown gene expression does not correlate with actual
DNL in the MCD model of steatohepatitis [6, 8]. MCD-
fed mice displayed marked suppression of mRNA encod-
ing acetyl-CoA carboxylase (ACC) and fatty acid synthase
(FAS) compared to MCS controls, as has been reported
previously [8] (Fig. 5d). There were no differences in lipo-
genic gene expression among the 3 custom MCD groups
that accumulated hepatic palmitate, but the predictive
value of this observation is low.
Noteworthy was that mice fed the MCD formula con-
taining both sucrose and palmitate accumulated more
hepatic palmitate and had higher ALT levels than would
have been predicted by a mere additive effect of both
nutrients (Fig. 5e). Dietary saturated fat is known to stimu-
late hepatic DNL [19], and thus the excess palmitate in
the livers of mice fed MCD sucrose-palmitate likely
derives from exaggerated DNL. The extremely high ALT
levels in these mice underscores that palmitate arising
from DNL is particularly noxious to the liver.
Overall, the current experiments confirm our previous
observation that dietary sucrose, through DNL conver-
sion to palmitate in the liver, is an important inducer of
liver injury when downstream pathways for fatty acid
Fig. 4 Hepatic inflammation and markers of fibrosis in mice fed custom MCD diets. a Photomicrographs illustrate infiltration of CD11b-positive
leukocytes (arrowheads) and Sirius Red staining for connective tissue (arrowhead) in mice fed custom MCD formulas for 21 days. Bar = 100 μm.
b Graphs depict CD11b-positive cells (average number of cells per 0.4 mm2 section) and relative hepatic expression of TNF, C-C chemokine
ligand-2 (CCL2), CXC chemokine ligand-2 (CXCL2) and type I collagen (COL1A1). Values represent mean ± SE for n = 5. MCD St Ol = MCD Starch
Oleate, MCD St Palm =MCD Starch Palmitate, MCD Suc Ol = MCD Sucrose Oleate, MCD Suc Palm =MCD Sucrose Palmitate. Superscripts indicate
P < 0.05 vs. comparison groups by number
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Fig. 5 Impact of MCD diets on hepatic palmitate accumulation and relation to liver injury. a Hepatic palmitate levels in mice fed MCS or MCD
diets for 21 days, measured by gas chromatography. Values represent mean ± SE for n = 5. St Ol = Starch Oleate, St Palm = Starch Palmitate, Suc
Ol = Sucrose Oleate, Suc Palm = Sucrose Palmitate. * P < 0.05 vs. MCS formula of the same nutrient composition. Numerical superscripts indicate
P < 0.05 vs. MCD comparison groups by number. b Scattergram demonstrating the relationship between total liver palmitate and serum ALT level
in individual MCD-fed mice. c Graph showing the relationship between mean hepatic palmitate level and serum ALT in the 4 MCD-fed groups.
Values represent mean ± SE for n = 10. d Hepatic expression of ACC and FAS mRNA in mice fed MCS or MCD diets for 21 days. Values represent
mean ± SE for n = 5. Numerical superscripts indicate P < 0.05 vs. MCD comparison groups by number. e Left graph represents total hepatic palmitate as
an estimate of the amount of excess palmitate attributable to the addition of palmitate, sucrose, or both to the MCD formula. Black segment
demonstrates the amount of palmitate present in the liver that was not predicted by a simple additive effect of palmitate and sucrose. Right
graph similarly represents serum ALT as an estimate of the amount of excess ALT attributable to the addition of palmitate, sucrose, or both to
the MCD formula. Black segment shows the amount of ALT that was not predicted by an additive effect of palmitate and sucrose. f Graph depicts total
liver palmitate within individual lipid compartments of MCS and MCD-fed livers: free fatty acids (FFA), diacylglycerols (DAG), cholesteryl esters (CE),
phospholipids (PL) and triglycerides (TG)
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desaturation and lipid excretion are blocked [6]. More
importantly, they extend previous work by demonstrating
that dietary palmitate does not induce the same level of
hepatotoxicity as DNL palmitate despite accruing to twice
the concentration found in control livers (Fig. 5c). This
suggests that dietary palmitate is handled differently by
the liver than DNL palmitate. Different metabolic fates for
DNL vs. exogenous palmitate have been reported in cul-
tured adipocytes and HepG2 cells [20, 21]. The noted dif-
ferences, however, were in palmitate desaturation and
elongation, which in MCD livers would not likely affect
lipotoxicity. We searched individual hepatic compartments
in MCD-fed mice to determine whether palmitate accumu-
lates preferentially in the more metabolic depots such as
free fatty acids or diacylglycerols, but found excess palmi-
tate only in hepatic triglycerides (Fig. 5f). It is possible that
liver injury is a function of the lability of the hepatic trigly-
ceride pool in these mice; we could not determine this in
the current experiments.
The fact that MCD starch-palmitate mice were relatively
free of liver injury, whereas MCD sucrose-palmitate mice
had exaggerated liver injury, supports the concept that
dietary saturated fat by itself is nearly innocuous to the
liver but becomes toxic only in combination with dietary
sugar. This is an intriguing theory, but unfortunately,
saturated fat consumption is unlikely to be uncoupled
from sugar consumption in free-living humans. Our other
major finding, that sucrose and palmitate together induce
synergistic hepatotoxicity in mice, is more translationally
relevant. Indeed, dietary saturated fat has recently been
shown to enhance hepatic steatosis, if not steatohepatitis,
in humans when added to a mixed-nutrient diet [22].
Given our current experimental results, it will be import-
ant to determine whether synergy between sucrose and
palmitate is an important inducer of liver injury when
taken out of the context of the MCD model. Such experi-
ments are currently underway.
Conclusion
In summary, this study demonstrates that saturated fatty
acids produced in the liver via DNL are more hepato-
toxic than those reaching the liver directly from the diet.
Our findings in mice parallel observations in humans
that DNL is an important contributor to fatty liver
disease, and suggest that in humans as well, sugar
consumption may be more harmful to the liver than
consumption of saturated fat. Importantly, our findings
indicate that a diet containing both sugar and saturated
fat is more harmful to the liver than a diet containing
either nutrient alone. This is likely related to synergy
between sugar and saturated fat in stmulating DNL.
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